Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA -2.66% shed 4.36% to $352.43 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.67% falling 1.55% to 15,537.69 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.09% falling 1.86% to 34,483.72. The stock's fall snapped a two-day winning streak. Moderna Inc. closed $145.06 below its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.44% fell 1.38% to $115.28, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +0.32% fell 2.26% to $198.88, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN -0.71% fell 1.26% to $54.83. Trading volume (24.7 M) eclipsed its 50-day average volume of 12.6 M.